Researchers develop a modified high-resolution magnetic resonance imaging technique for determining the location of ...
The diagnostic imaging equipment market is largely propelled by the increasing incidence of chronic illnesses such as cardiovascular diseases, cancer, ...
Milford Regional Medical Center and Shields Health announced a new joint venture partnership to provide advanced imaging services at two locations in Milford. Magnetic Resonance Imaging (MRI) services ...
A study published in Annals of Neurology has found that individuals with chronic back pain exhibit significantly higher ...
Singapore Business Review on MSN
SingHealth opens off-site MRI centre at Dunearn Village
It features three new machines, boosting annual capacity by up to 18,000 slots. SingHealth has opened a new off-site magnetic resonance imaging (MRI) centre at Dunearn Village, with three machines ...
A world-first trial of Australian men has confirmed a specialised scan can accurately “light up” prostate cancer, saving unnecessary and painful biopsies and stress of over-diagnosis.
Now an associate professor of biomedical informatics at Columbia University, Elhadad is far from alone. Endometriosis—a ...
Prostate cancer is one of the leading causes of cancer-related death in men, and some experts project the number of cases to rise over the coming decades. But in a recent Urologic Oncology article, ...
The diagnostic imaging equipment market is largely propelled by the increasing incidence of chronic illnesses such as cardiovascular diseases, cancer, neurological disorders, and orthopedic ...
Neuroscientists have uncovered new insights into a key evolutionary question: Why can humans talk when most animals can't? The journal Science published the research led by Emory University and the ...
Researchers have identified a network of connections linking the brainstem and spinal cord that helps control hand and arm movements, revealing an unexpected layer of the nervous system enabling ...
GlobalData on MSN
Gesynta Pharma doses first patient in Phase II NOVA trial
The trial plans to enrol around 190 women aged 18 to 45 years across seven European countries.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results